Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system

Documenti analoghi

• Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure
  di: Prébet, Thomas, et al.
  Pubblicazione: (2012)
• Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure
  di: Prébet, Thomas, et al.
  Pubblicazione: (2011)
• Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure
  di: Prébet, Thomas, et al.
  Pubblicazione: (2013)
• The role of azacitidine in the management of myelodysplastic syndromes (MDS)
  di: Götze, KS, et al.
  Pubblicazione: (2009)
• MDS-specific comorbidity index is useful to identify myelodysplastic patients who can have better outcome with 5-azacitidine
  di: Breccia, Massimo, et al.
  Pubblicazione: (2012)